Kodiak Sciences is trading at $102.99 (+4.55%) after-hours; no clear new company announcement explains the move.

  • Its Phase 3 DAYBREAK results were announced September 28, not November 4.
  • Broader markets rallied November 4 after Democrats took control of Congress; investors responded to greater political clarity, a possible backdrop but not a confirmed cause.
  • LifeSci Capital raised its target to $145 from $85 and kept an Outperform rating; its report dates the action to Monday, not November 4.